unintended pregnancies occur worldword


Total Prescriptions

of Evofem's contraceptive as of September 2021


Million Women

comprise the total US contraceptive market

The Path to Drawdown: Contraceptives

About 225 million women in lower-income countries lack the ability to choose whether and when to become pregnant. That leads to some 75 million unintended pregnancies each year. There's a similar deficiency in contraceptives in high-income countries, too. In the United States, for instance, nearly half of all pregnancies are unintended. 

Securing the right to voluntary, high-quality family planning services and contraception around the world would have significant benefits on the health, welfare, and life expectancy of both women and their children.

Contraceptives, family planning and resources for women's health would also hugely benefit the environment. Every person in the world consumes resources and causes emissions throughout their life. If contraceptives are widely provided and women's health are secured, a more stable population size could help avoid up to 85.42 gigatons of greenhouse gases between 2020 and 2050.


Evofem Biosciences, Inc. (stock ticker: EVFM) is a biopharmaceutical company that offers a hormone-free contraceptive vaginal gel that is applied before sex. They are also working on a vaginal gel that reduces certain infections. 

EVFM's Role in Drawdown

Evofem's flagship product, Phexxi, is an FDA-approved hormone-free prescription contraception that can be used only when women need it. It is a vaginal gel that's applied before sex and it acts as a contraceptive by keeping vaginal pH in the baseline range to make it difficult for semen to swim up the reproductive canal.

By providing women with more control over their sexual and reproductive health, Evofem contributes to the Drawdown solution of women's health.

EVFM: What We Like

We'll update this section once Evofem makes sustainability information available.

EVFM: What We Want to See Improve

Disclose Climate-Related Information

As of now, Evofem doesn't make any sustainability or climate-related information available. While we don't think Evofem is responsible for large amounts of direct emissions and waste, we'd like to know the key sustainability metrics of the manufacturers and distributors they rely on. Evofem should thus publish an annual sustainability report that includes metrics on scope 1, 2 and 3 emissions, energy and water use, and waste generated.

Set Clear Targets

Once sustainability metrics are disclosed, we'd like Evofem to propose ways to cut their emissions and enhance their energy and water efficiency. Their sustainability reports should then contain specific targets for the years 2025, 2030 and 2050 that make the company greener and zero-emissions. 

Switch to EVs and Clean Energy

Evofem reports (p. 18-19) that they leased a total of 74 vehicles from a car rental company as of June 2021, and that they entered into an office lease of ~24,474 square feet for the period between April 2020 and September 2025. Several ways to significantly cut their emissions and energy use is to switch to electric vehicles for their fleet, purchase renewable and clean electricity for their office building, and implement energy efficiency and building automation technologies in their facility. 

Other Contraceptives Stocks in the Climate Index

Attend Our Next Webinar

Attend Our Next Webinar

Join our next Sustainable Investing 101 webinar, get our favorite DIY options, and walk through how we build our portfolios.

Get Our Newsletter

Get Our Newsletter

Go a level deeper with us and investigate the potential impacts of climate change on investments like your retirement account.

Join Newsletter
Talk To A Human

Talk To A Human

Joining a new investment service can be intimidating. We’re here for you. Click below to email us a question or book a quick call.

Ask a Question